Biology of double-hit B-cell lymphomas

scientific article

Biology of double-hit B-cell lymphomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MOH.0B013E328353BBBD
P932PMC publication ID3389520
P698PubMed publication ID22504522

P50authorColeman LindsleyQ63968799
Ann S LaCasceQ89672650
P2860cites workFrequent mutation of histone-modifying genes in non-Hodgkin lymphomaQ24630610
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaQ27824784
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomasQ28207345
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphomaQ33800442
Analysis of the coding genome of diffuse large B-cell lymphomaQ34205133
Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variantQ34245324
Atypical Burkitt's lymphoma transforming from follicular lymphomaQ35128743
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphomaQ35153156
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocationsQ37246742
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalQ37351043
Prognostic factors in follicular lymphoma.Q37729612
Double-hit B-cell lymphomasQ37813897
Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literatureQ37834361
The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspectiveQ37863996
Pathogenesis of non-Hodgkin's lymphomaQ37863998
BCL2 and MYC dual-hit lymphoma/leukemiaQ37882924
Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patientsQ37899197
Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocationsQ40009448
Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximabQ43055328
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomaQ44685328
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter TrialQ45158002
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.Q46892396
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.Q51940347
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.Q53143775
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.Q53209748
Prognostic significance of secondary cytogenetic alterations in follicular lymphomas.Q53318271
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.Q54561742
C-MYCtranslocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?Q58001496
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcomeQ60609610
Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentationQ77766595
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosisQ81419860
Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysisQ82045598
Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center originQ83025611
Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experienceQ84142787
Several lymphoma‐specific genetic events in parallel can be found in mature B‐cell neoplasmsQ85226574
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)299-304
P577publication date2012-07-01
P1433published inCurrent Opinion in HematologyQ15757961
P1476titleBiology of double-hit B-cell lymphomas
P478volume19

Reverse relations

cites work (P2860)
Q44731136Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung Cancers
Q38261916Double hit lymphoma - a case of unusual response after sequential aggressive chemotherapy and review of the literature
Q89824182Educational Case: Gastric High-Grade B-Cell Lymphoma With MYC and BCL2 Gene Rearrangement (Double-Hit Lymphoma)
Q47576770Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
Q37621025Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Q38252661Replication initiation and genome instability: a crossroads for DNA and RNA synthesis.
Q60916539Targeting the Bcl-2 Family in B Cell Lymphoma
Q38124735The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma
Q45287423The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Q85494492Which treatment for high-risk patients with DLBCL?

Search more.